In-vitro carboxymethylation of low density lipoprotein alters its metabolism via the high-affinity receptor
- PMID: 8330857
- DOI: 10.1055/s-2007-1002089
In-vitro carboxymethylation of low density lipoprotein alters its metabolism via the high-affinity receptor
Abstract
Carboxymethylation of lysine residues has been shown to result from oxidation of glycated proteins in vivo and in vitro leading to an augmentation of proteins' net negative charge. The metabolism of carboxymethylated low density lipoprotein (LDL) was studied in cultured human fibroblasts and mouse peritoneal macrophages. In vitro carboxymethylation was achieved by incubation of LDL with glyoxylic acid in the presence of Na(CN)BH3. Carboxymethylation inhibited metabolism of LDL via the high affinity receptor in fibroblasts as did methylation. The uptake of LDL into mouse peritoneal macrophages via the scavenger receptor, which was stimulated by acetylation, was not affected.
Similar articles
-
[Lipid biosynthesis and metabolism of native and acetylated low density lipoproteins in macrophages stimulated by zymosan in vivo and in vitro].Biokhimiia. 1992 Aug;57(8):1181-91. Biokhimiia. 1992. PMID: 1391222 Russian.
-
Carboxymethylated beta-1,3-glucan inhibits the binding and degradation of acetylated low density lipoproteins in macrophages in vitro and modulates their plasma clearance in vivo.Cell Biochem Funct. 1996 Sep;14(3):209-17. doi: 10.1002/cbf.685. Cell Biochem Funct. 1996. PMID: 8888575
-
Phospholipase D-modified low density lipoprotein is taken up by macrophages at increased rate. A possible role for phosphatidic acid.J Clin Invest. 1993 May;91(5):1942-52. doi: 10.1172/JCI116413. J Clin Invest. 1993. PMID: 8486764 Free PMC article.
-
Role of oxidized low density lipoprotein in atherogenesis.Prog Lipid Res. 1992;31(2):127-43. doi: 10.1016/0163-7827(92)90006-5. Prog Lipid Res. 1992. PMID: 1461917 Review. No abstract available.
-
Low-density lipoprotein receptors in the uptake of tumour photosensitizers by human and rat transformed fibroblasts.Int J Biochem Cell Biol. 2002 Jan;34(1):10-23. doi: 10.1016/s1357-2725(01)00092-9. Int J Biochem Cell Biol. 2002. PMID: 11733181 Review.
Cited by
-
Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Heart Fail Rev. 2014 Jan;19(1):49-63. doi: 10.1007/s10741-013-9374-y. Heart Fail Rev. 2014. PMID: 23404649 Review.
-
Advanced glycation end products and risk of general and abdominal obesity in Iranian adults: Tehran lipid and glucose study.Med J Islam Repub Iran. 2019 Mar 25;33:21. doi: 10.34171/mjiri.33.21. eCollection 2019. Med J Islam Repub Iran. 2019. PMID: 31380311 Free PMC article.
-
The Advanced Glycation End-Products (AGE)-Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases.Int J Mol Sci. 2025 Apr 14;26(8):3707. doi: 10.3390/ijms26083707. Int J Mol Sci. 2025. PMID: 40332316 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources